Related Experiment Videos
Effects of sodium valproate in 100 children with special reference to weight
Insights
Sodium valproate is linked to weight gain in children with epilepsy. While generally safe, milder side effects like weight gain and gastrointestinal issues are common in epilepsy patients.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Epileptology
Background:
- Sodium valproate is a common antiepileptic drug.
- Weight gain is a known side effect of sodium valproate.
- Drug interactions can lead to adverse events, as seen with sodium valproate and phenytoin.
Purpose of the Study:
- To evaluate the efficacy and safety of sodium valproate in children with epilepsy.
- To identify the incidence and types of side effects associated with sodium valproate treatment.
- To assess the impact of sodium valproate on seizure control and overall well-being.
Main Methods:
- Retrospective analysis of 100 children with epilepsy treated with sodium valproate.
- Review of patient records for seizure control, side effects, and treatment outcomes.
- Categorization of side effects by type and frequency.
Main Results:
- Seizure control improved in 77% of children, particularly those with generalized epilepsy.
- No severe side effects like acute liver disease or pancreatitis were observed.
- Common milder side effects included weight gain (44%), gastrointestinal disturbances (20%), lassitude (9%), hair loss (6%), enuresis (7%), and aggressive behavior (4%).
Conclusions:
- Sodium valproate is effective in controlling seizures in children, especially with generalized epilepsy.
- While severe adverse events are rare, milder side effects, notably weight gain, are frequent and require monitoring.
- Careful patient management is essential to mitigate potential side effects and optimize treatment outcomes.
Abstract:
Excessive weight gain occurred in a patient who was taking sodium valproate and phenytoin. The sodium valproate was therefore withdrawn but the rapid weight loss that ensued led to phenytoin intoxication. Hence a retrospective analysis was conducted of 100 children with epilepsy treated with sodium valproate. Fit control improved in 77 and was best in children with generalised epilepsy. None of the reported severe side effects, such as acute liver disease and pancreatitis, were encountered. Milder but troublesome side effects, however, occurred in 65 patients. The commonest was increased weight gain, which occurred in 44 cases. Others were transient gastrointestinal disturbances (20), lassitude (nine), transient hair loss (six), transient enuresis (seven), and aggressive behaviour (four).